Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system
Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and...
Covered in this story
What has happened since
- Medtronic is up 4.3% since this was published, 36 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Medtronic
- Mizuho: $92.2 → $115 by Sep 2027 · Outperform via Investing.com
- Stifel: $92.2 → $95 by Sep 2027 · Hold via Investing.com
- Needham: $92 → $114 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MDT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Medtronic →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.